A carregar...
Publicação
How cells and biomaterials from natural origin are revolutionizing tissue engineering and regenerative medicine
| Nome: | Descrição: | Tamanho: | Formato: | |
|---|---|---|---|---|
| 465.65 KB | Adobe PDF |
Autores
Orientador(es)
Resumo(s)
Tissue engineering and regenerative medicine aim to restore damaged tissues by combining human cells with biomaterials that provide structure and biological cues. After decades of progress from early scaffold-based approaches to today’s biofabrication methods, the field is moving toward therapies that are more precise, more patient-specific, and more biologically faithful. This article presents the key ingredients required to engineer tissues (cells, matrices, biochemical signals and culture conditions) and why biomaterials are central to success. Emphasis is placed on polymers of natural origin, including polysaccharides and proteins sourced from plants, animals and especially the marine environment (e.g., alginate, carrageenans and chitosan), as well as human-derived materials obtained from blood fractions (platelet lysate) and perinatal tissues (amnion, chorion, umbilical cord, placenta). We describe how these macromolecules can be processed into porous scaffolds or, increasingly, into hydrogels-water-rich macromolecular networks that mimic the extracellular matrix. By adding photocrosslinkable groups, natural polymers can be solidified with light, enabling rapid gelation, spatial patterning and 3D bioprinting of complex constructs. We introduce bottom-up tissue engineering, where small cell-laden building blocks assemble into hierarchical tissues, and show how the same technologies used to build healthy tissues can also create 3D disease models for drug testing and precision medicine. Finally, we highlight emerging applications beyond healthcare, including soft biohybrid robotics and cultivated meat.
Descrição
Palavras-chave
Contexto Educativo
Citação
Editora
Licença CC
Sem licença CC